Medical Devices & Consumables
Global Oncostatin M (OSM) Market Research Report 2025
- Jun 28, 25
- ID: 344036
- Pages: 102
- Figures: 99
- Views: 33
The global market for Oncostatin M (OSM) was valued at US$ 107 million in the year 2024 and is projected to reach a revised size of US$ 198 million by 2031, growing at a CAGR of 9.0% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oncostatin M (OSM) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Oncostatin M (OSM) is a growth differentiation factor involved in the regulation of neurogenesis, osteogenesis, and hematopoiesis. It stimulates the proliferation of fibroblasts, smooth muscle cells, and Kaposi's sarcoma cells, but inhibits the growth of some normal and tumor cell lines. It also promotes the release of cytokines (such as IL-6, GM-CSF, and g-CSF) from endothelial cells and enhances the expression of low-density lipoprotein receptors in hepatoma cells. OSM is produced by activated T cells, monocytes, and Kaposi's sarcoma cells and has stimulatory and inhibitory effects on cell proliferation.
North American market for Oncostatin M (OSM) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncostatin M (OSM) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oncostatin M (OSM) include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncostatin M (OSM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncostatin M (OSM).
The Oncostatin M (OSM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncostatin M (OSM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncostatin M (OSM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
ENZO
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
Segment by Type
Purity＜95%
Purity ≥95%
Segment by Application
University
Research Center
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oncostatin M (OSM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oncostatin M (OSM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oncostatin M (OSM) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Oncostatin M (OSM) is a growth differentiation factor involved in the regulation of neurogenesis, osteogenesis, and hematopoiesis. It stimulates the proliferation of fibroblasts, smooth muscle cells, and Kaposi's sarcoma cells, but inhibits the growth of some normal and tumor cell lines. It also promotes the release of cytokines (such as IL-6, GM-CSF, and g-CSF) from endothelial cells and enhances the expression of low-density lipoprotein receptors in hepatoma cells. OSM is produced by activated T cells, monocytes, and Kaposi's sarcoma cells and has stimulatory and inhibitory effects on cell proliferation.
North American market for Oncostatin M (OSM) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncostatin M (OSM) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oncostatin M (OSM) include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncostatin M (OSM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncostatin M (OSM).
The Oncostatin M (OSM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncostatin M (OSM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncostatin M (OSM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
ENZO
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
Segment by Type
Purity＜95%
Purity ≥95%
Segment by Application
University
Research Center
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oncostatin M (OSM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oncostatin M (OSM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Oncostatin M (OSM) Market Overview
1.1 Product Definition
1.2 Oncostatin M (OSM) by Type
1.2.1 Global Oncostatin M (OSM) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Oncostatin M (OSM) by Application
1.3.1 Global Oncostatin M (OSM) Market Value by Application (2024 VS 2031)
1.3.2 University
1.3.3 Research Center
1.4 Global Oncostatin M (OSM) Market Size Estimates and Forecasts
1.4.1 Global Oncostatin M (OSM) Revenue 2020-2031
1.4.2 Global Oncostatin M (OSM) Sales 2020-2031
1.4.3 Global Oncostatin M (OSM) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oncostatin M (OSM) Market Competition by Manufacturers
2.1 Global Oncostatin M (OSM) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oncostatin M (OSM) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oncostatin M (OSM) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oncostatin M (OSM), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncostatin M (OSM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncostatin M (OSM), Product Type & Application
2.7 Global Key Manufacturers of Oncostatin M (OSM), Date of Enter into This Industry
2.8 Global Oncostatin M (OSM) Market Competitive Situation and Trends
2.8.1 Global Oncostatin M (OSM) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oncostatin M (OSM) Players Market Share by Revenue
2.8.3 Global Oncostatin M (OSM) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oncostatin M (OSM) Market Scenario by Region
3.1 Global Oncostatin M (OSM) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oncostatin M (OSM) Sales by Region: 2020-2031
3.2.1 Global Oncostatin M (OSM) Sales by Region: 2020-2025
3.2.2 Global Oncostatin M (OSM) Sales by Region: 2026-2031
3.3 Global Oncostatin M (OSM) Revenue by Region: 2020-2031
3.3.1 Global Oncostatin M (OSM) Revenue by Region: 2020-2025
3.3.2 Global Oncostatin M (OSM) Revenue by Region: 2026-2031
3.4 North America Oncostatin M (OSM) Market Facts & Figures by Country
3.4.1 North America Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oncostatin M (OSM) Sales by Country (2020-2031)
3.4.3 North America Oncostatin M (OSM) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncostatin M (OSM) Market Facts & Figures by Country
3.5.1 Europe Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oncostatin M (OSM) Sales by Country (2020-2031)
3.5.3 Europe Oncostatin M (OSM) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncostatin M (OSM) Market Facts & Figures by Region
3.6.1 Asia Pacific Oncostatin M (OSM) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oncostatin M (OSM) Sales by Region (2020-2031)
3.6.3 Asia Pacific Oncostatin M (OSM) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncostatin M (OSM) Market Facts & Figures by Country
3.7.1 Latin America Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oncostatin M (OSM) Sales by Country (2020-2031)
3.7.3 Latin America Oncostatin M (OSM) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oncostatin M (OSM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oncostatin M (OSM) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oncostatin M (OSM) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncostatin M (OSM) Sales by Type (2020-2031)
4.1.1 Global Oncostatin M (OSM) Sales by Type (2020-2025)
4.1.2 Global Oncostatin M (OSM) Sales by Type (2026-2031)
4.1.3 Global Oncostatin M (OSM) Sales Market Share by Type (2020-2031)
4.2 Global Oncostatin M (OSM) Revenue by Type (2020-2031)
4.2.1 Global Oncostatin M (OSM) Revenue by Type (2020-2025)
4.2.2 Global Oncostatin M (OSM) Revenue by Type (2026-2031)
4.2.3 Global Oncostatin M (OSM) Revenue Market Share by Type (2020-2031)
4.3 Global Oncostatin M (OSM) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oncostatin M (OSM) Sales by Application (2020-2031)
5.1.1 Global Oncostatin M (OSM) Sales by Application (2020-2025)
5.1.2 Global Oncostatin M (OSM) Sales by Application (2026-2031)
5.1.3 Global Oncostatin M (OSM) Sales Market Share by Application (2020-2031)
5.2 Global Oncostatin M (OSM) Revenue by Application (2020-2031)
5.2.1 Global Oncostatin M (OSM) Revenue by Application (2020-2025)
5.2.2 Global Oncostatin M (OSM) Revenue by Application (2026-2031)
5.2.3 Global Oncostatin M (OSM) Revenue Market Share by Application (2020-2031)
5.3 Global Oncostatin M (OSM) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific Inc.
6.1.1 Thermo Fisher Scientific Inc. Company Information
6.1.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.1.3 Thermo Fisher Scientific Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Inc. Oncostatin M (OSM) Product Portfolio
6.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne Oncostatin M (OSM) Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Scientists Helping Scientists
6.3.1 Scientists Helping Scientists Company Information
6.3.2 Scientists Helping Scientists Description and Business Overview
6.3.3 Scientists Helping Scientists Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Scientists Helping Scientists Oncostatin M (OSM) Product Portfolio
6.3.5 Scientists Helping Scientists Recent Developments/Updates
6.4 Abcam Limited
6.4.1 Abcam Limited Company Information
6.4.2 Abcam Limited Description and Business Overview
6.4.3 Abcam Limited Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abcam Limited Oncostatin M (OSM) Product Portfolio
6.4.5 Abcam Limited Recent Developments/Updates
6.5 FUJIFILM Irvine Scientific
6.5.1 FUJIFILM Irvine Scientific Company Information
6.5.2 FUJIFILM Irvine Scientific Description and Business Overview
6.5.3 FUJIFILM Irvine Scientific Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FUJIFILM Irvine Scientific Oncostatin M (OSM) Product Portfolio
6.5.5 FUJIFILM Irvine Scientific Recent Developments/Updates
6.6 BD Biosciences
6.6.1 BD Biosciences Company Information
6.6.2 BD Biosciences Description and Business Overview
6.6.3 BD Biosciences Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD Biosciences Oncostatin M (OSM) Product Portfolio
6.6.5 BD Biosciences Recent Developments/Updates
6.7 Bio-Rad Laboratories, Inc.
6.7.1 Bio-Rad Laboratories, Inc. Company Information
6.7.2 Bio-Rad Laboratories, Inc. Description and Business Overview
6.7.3 Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Product Portfolio
6.7.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.8 BPS Bioscience, Inc.
6.8.1 BPS Bioscience, Inc. Company Information
6.8.2 BPS Bioscience, Inc. Description and Business Overview
6.8.3 BPS Bioscience, Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BPS Bioscience, Inc. Oncostatin M (OSM) Product Portfolio
6.8.5 BPS Bioscience, Inc. Recent Developments/Updates
6.9 Elabscience
6.9.1 Elabscience Company Information
6.9.2 Elabscience Description and Business Overview
6.9.3 Elabscience Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Elabscience Oncostatin M (OSM) Product Portfolio
6.9.5 Elabscience Recent Developments/Updates
6.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
6.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
6.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
6.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
6.11 ENZO
6.11.1 ENZO Company Information
6.11.2 ENZO Description and Business Overview
6.11.3 ENZO Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ENZO Oncostatin M (OSM) Product Portfolio
6.11.5 ENZO Recent Developments/Updates
6.12 Beijing Biocreative Technology Co., Ltd.
6.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
6.12.2 Beijing Biocreative Technology Co., Ltd. Description and Business Overview
6.12.3 Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.12.5 Beijing Biocreative Technology Co., Ltd. Recent Developments/Updates
6.13 Shanghai Yaji Biotechnology Co., Ltd.
6.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
6.13.2 Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
6.13.3 Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Developments/Updates
6.14 Cellverse Co., Ltd.
6.14.1 Cellverse Co., Ltd. Company Information
6.14.2 Cellverse Co., Ltd. Description and Business Overview
6.14.3 Cellverse Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cellverse Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.14.5 Cellverse Co., Ltd. Recent Developments/Updates
6.15 Dalian Meilun Biotech Co., Ltd.
6.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
6.15.2 Dalian Meilun Biotech Co., Ltd. Description and Business Overview
6.15.3 Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.15.5 Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
6.16 Sino Biological,Inc.
6.16.1 Sino Biological,Inc. Company Information
6.16.2 Sino Biological,Inc. Description and Business Overview
6.16.3 Sino Biological,Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sino Biological,Inc. Oncostatin M (OSM) Product Portfolio
6.16.5 Sino Biological,Inc. Recent Developments/Updates
6.17 Prospec-Tany Technogene Ltd
6.17.1 Prospec-Tany Technogene Ltd Company Information
6.17.2 Prospec-Tany Technogene Ltd Description and Business Overview
6.17.3 Prospec-Tany Technogene Ltd Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Prospec-Tany Technogene Ltd Oncostatin M (OSM) Product Portfolio
6.17.5 Prospec-Tany Technogene Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncostatin M (OSM) Industry Chain Analysis
7.2 Oncostatin M (OSM) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncostatin M (OSM) Production Mode & Process Analysis
7.4 Oncostatin M (OSM) Sales and Marketing
7.4.1 Oncostatin M (OSM) Sales Channels
7.4.2 Oncostatin M (OSM) Distributors
7.5 Oncostatin M (OSM) Customer Analysis
8 Oncostatin M (OSM) Market Dynamics
8.1 Oncostatin M (OSM) Industry Trends
8.2 Oncostatin M (OSM) Market Drivers
8.3 Oncostatin M (OSM) Market Challenges
8.4 Oncostatin M (OSM) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Oncostatin M (OSM) by Type
1.2.1 Global Oncostatin M (OSM) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity＜95%
1.2.3 Purity ≥95%
1.3 Oncostatin M (OSM) by Application
1.3.1 Global Oncostatin M (OSM) Market Value by Application (2024 VS 2031)
1.3.2 University
1.3.3 Research Center
1.4 Global Oncostatin M (OSM) Market Size Estimates and Forecasts
1.4.1 Global Oncostatin M (OSM) Revenue 2020-2031
1.4.2 Global Oncostatin M (OSM) Sales 2020-2031
1.4.3 Global Oncostatin M (OSM) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oncostatin M (OSM) Market Competition by Manufacturers
2.1 Global Oncostatin M (OSM) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oncostatin M (OSM) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oncostatin M (OSM) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oncostatin M (OSM), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncostatin M (OSM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncostatin M (OSM), Product Type & Application
2.7 Global Key Manufacturers of Oncostatin M (OSM), Date of Enter into This Industry
2.8 Global Oncostatin M (OSM) Market Competitive Situation and Trends
2.8.1 Global Oncostatin M (OSM) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oncostatin M (OSM) Players Market Share by Revenue
2.8.3 Global Oncostatin M (OSM) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oncostatin M (OSM) Market Scenario by Region
3.1 Global Oncostatin M (OSM) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oncostatin M (OSM) Sales by Region: 2020-2031
3.2.1 Global Oncostatin M (OSM) Sales by Region: 2020-2025
3.2.2 Global Oncostatin M (OSM) Sales by Region: 2026-2031
3.3 Global Oncostatin M (OSM) Revenue by Region: 2020-2031
3.3.1 Global Oncostatin M (OSM) Revenue by Region: 2020-2025
3.3.2 Global Oncostatin M (OSM) Revenue by Region: 2026-2031
3.4 North America Oncostatin M (OSM) Market Facts & Figures by Country
3.4.1 North America Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oncostatin M (OSM) Sales by Country (2020-2031)
3.4.3 North America Oncostatin M (OSM) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncostatin M (OSM) Market Facts & Figures by Country
3.5.1 Europe Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oncostatin M (OSM) Sales by Country (2020-2031)
3.5.3 Europe Oncostatin M (OSM) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncostatin M (OSM) Market Facts & Figures by Region
3.6.1 Asia Pacific Oncostatin M (OSM) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oncostatin M (OSM) Sales by Region (2020-2031)
3.6.3 Asia Pacific Oncostatin M (OSM) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncostatin M (OSM) Market Facts & Figures by Country
3.7.1 Latin America Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oncostatin M (OSM) Sales by Country (2020-2031)
3.7.3 Latin America Oncostatin M (OSM) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oncostatin M (OSM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncostatin M (OSM) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oncostatin M (OSM) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oncostatin M (OSM) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncostatin M (OSM) Sales by Type (2020-2031)
4.1.1 Global Oncostatin M (OSM) Sales by Type (2020-2025)
4.1.2 Global Oncostatin M (OSM) Sales by Type (2026-2031)
4.1.3 Global Oncostatin M (OSM) Sales Market Share by Type (2020-2031)
4.2 Global Oncostatin M (OSM) Revenue by Type (2020-2031)
4.2.1 Global Oncostatin M (OSM) Revenue by Type (2020-2025)
4.2.2 Global Oncostatin M (OSM) Revenue by Type (2026-2031)
4.2.3 Global Oncostatin M (OSM) Revenue Market Share by Type (2020-2031)
4.3 Global Oncostatin M (OSM) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oncostatin M (OSM) Sales by Application (2020-2031)
5.1.1 Global Oncostatin M (OSM) Sales by Application (2020-2025)
5.1.2 Global Oncostatin M (OSM) Sales by Application (2026-2031)
5.1.3 Global Oncostatin M (OSM) Sales Market Share by Application (2020-2031)
5.2 Global Oncostatin M (OSM) Revenue by Application (2020-2031)
5.2.1 Global Oncostatin M (OSM) Revenue by Application (2020-2025)
5.2.2 Global Oncostatin M (OSM) Revenue by Application (2026-2031)
5.2.3 Global Oncostatin M (OSM) Revenue Market Share by Application (2020-2031)
5.3 Global Oncostatin M (OSM) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific Inc.
6.1.1 Thermo Fisher Scientific Inc. Company Information
6.1.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.1.3 Thermo Fisher Scientific Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Inc. Oncostatin M (OSM) Product Portfolio
6.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne Oncostatin M (OSM) Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Scientists Helping Scientists
6.3.1 Scientists Helping Scientists Company Information
6.3.2 Scientists Helping Scientists Description and Business Overview
6.3.3 Scientists Helping Scientists Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Scientists Helping Scientists Oncostatin M (OSM) Product Portfolio
6.3.5 Scientists Helping Scientists Recent Developments/Updates
6.4 Abcam Limited
6.4.1 Abcam Limited Company Information
6.4.2 Abcam Limited Description and Business Overview
6.4.3 Abcam Limited Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abcam Limited Oncostatin M (OSM) Product Portfolio
6.4.5 Abcam Limited Recent Developments/Updates
6.5 FUJIFILM Irvine Scientific
6.5.1 FUJIFILM Irvine Scientific Company Information
6.5.2 FUJIFILM Irvine Scientific Description and Business Overview
6.5.3 FUJIFILM Irvine Scientific Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FUJIFILM Irvine Scientific Oncostatin M (OSM) Product Portfolio
6.5.5 FUJIFILM Irvine Scientific Recent Developments/Updates
6.6 BD Biosciences
6.6.1 BD Biosciences Company Information
6.6.2 BD Biosciences Description and Business Overview
6.6.3 BD Biosciences Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD Biosciences Oncostatin M (OSM) Product Portfolio
6.6.5 BD Biosciences Recent Developments/Updates
6.7 Bio-Rad Laboratories, Inc.
6.7.1 Bio-Rad Laboratories, Inc. Company Information
6.7.2 Bio-Rad Laboratories, Inc. Description and Business Overview
6.7.3 Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Product Portfolio
6.7.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.8 BPS Bioscience, Inc.
6.8.1 BPS Bioscience, Inc. Company Information
6.8.2 BPS Bioscience, Inc. Description and Business Overview
6.8.3 BPS Bioscience, Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BPS Bioscience, Inc. Oncostatin M (OSM) Product Portfolio
6.8.5 BPS Bioscience, Inc. Recent Developments/Updates
6.9 Elabscience
6.9.1 Elabscience Company Information
6.9.2 Elabscience Description and Business Overview
6.9.3 Elabscience Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Elabscience Oncostatin M (OSM) Product Portfolio
6.9.5 Elabscience Recent Developments/Updates
6.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
6.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
6.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
6.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
6.11 ENZO
6.11.1 ENZO Company Information
6.11.2 ENZO Description and Business Overview
6.11.3 ENZO Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ENZO Oncostatin M (OSM) Product Portfolio
6.11.5 ENZO Recent Developments/Updates
6.12 Beijing Biocreative Technology Co., Ltd.
6.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
6.12.2 Beijing Biocreative Technology Co., Ltd. Description and Business Overview
6.12.3 Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.12.5 Beijing Biocreative Technology Co., Ltd. Recent Developments/Updates
6.13 Shanghai Yaji Biotechnology Co., Ltd.
6.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
6.13.2 Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
6.13.3 Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Developments/Updates
6.14 Cellverse Co., Ltd.
6.14.1 Cellverse Co., Ltd. Company Information
6.14.2 Cellverse Co., Ltd. Description and Business Overview
6.14.3 Cellverse Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Cellverse Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.14.5 Cellverse Co., Ltd. Recent Developments/Updates
6.15 Dalian Meilun Biotech Co., Ltd.
6.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
6.15.2 Dalian Meilun Biotech Co., Ltd. Description and Business Overview
6.15.3 Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Product Portfolio
6.15.5 Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
6.16 Sino Biological,Inc.
6.16.1 Sino Biological,Inc. Company Information
6.16.2 Sino Biological,Inc. Description and Business Overview
6.16.3 Sino Biological,Inc. Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sino Biological,Inc. Oncostatin M (OSM) Product Portfolio
6.16.5 Sino Biological,Inc. Recent Developments/Updates
6.17 Prospec-Tany Technogene Ltd
6.17.1 Prospec-Tany Technogene Ltd Company Information
6.17.2 Prospec-Tany Technogene Ltd Description and Business Overview
6.17.3 Prospec-Tany Technogene Ltd Oncostatin M (OSM) Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Prospec-Tany Technogene Ltd Oncostatin M (OSM) Product Portfolio
6.17.5 Prospec-Tany Technogene Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncostatin M (OSM) Industry Chain Analysis
7.2 Oncostatin M (OSM) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncostatin M (OSM) Production Mode & Process Analysis
7.4 Oncostatin M (OSM) Sales and Marketing
7.4.1 Oncostatin M (OSM) Sales Channels
7.4.2 Oncostatin M (OSM) Distributors
7.5 Oncostatin M (OSM) Customer Analysis
8 Oncostatin M (OSM) Market Dynamics
8.1 Oncostatin M (OSM) Industry Trends
8.2 Oncostatin M (OSM) Market Drivers
8.3 Oncostatin M (OSM) Market Challenges
8.4 Oncostatin M (OSM) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oncostatin M (OSM) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oncostatin M (OSM) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oncostatin M (OSM) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oncostatin M (OSM) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oncostatin M (OSM) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oncostatin M (OSM) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oncostatin M (OSM) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oncostatin M (OSM) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oncostatin M (OSM), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oncostatin M (OSM), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncostatin M (OSM), Product Type & Application
Table 12. Global Key Manufacturers of Oncostatin M (OSM), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncostatin M (OSM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncostatin M (OSM) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncostatin M (OSM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oncostatin M (OSM) Sales by Region (2020-2025) & (K Units)
Table 18. Global Oncostatin M (OSM) Sales Market Share by Region (2020-2025)
Table 19. Global Oncostatin M (OSM) Sales by Region (2026-2031) & (K Units)
Table 20. Global Oncostatin M (OSM) Sales Market Share by Region (2026-2031)
Table 21. Global Oncostatin M (OSM) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oncostatin M (OSM) Revenue Market Share by Region (2020-2025)
Table 23. Global Oncostatin M (OSM) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oncostatin M (OSM) Revenue Market Share by Region (2026-2031)
Table 25. North America Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 27. North America Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 28. North America Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oncostatin M (OSM) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oncostatin M (OSM) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oncostatin M (OSM) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oncostatin M (OSM) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oncostatin M (OSM) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oncostatin M (OSM) Sales (K Units) by Type (2020-2025)
Table 51. Global Oncostatin M (OSM) Sales (K Units) by Type (2026-2031)
Table 52. Global Oncostatin M (OSM) Sales Market Share by Type (2020-2025)
Table 53. Global Oncostatin M (OSM) Sales Market Share by Type (2026-2031)
Table 54. Global Oncostatin M (OSM) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oncostatin M (OSM) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oncostatin M (OSM) Revenue Market Share by Type (2020-2025)
Table 57. Global Oncostatin M (OSM) Revenue Market Share by Type (2026-2031)
Table 58. Global Oncostatin M (OSM) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oncostatin M (OSM) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oncostatin M (OSM) Sales (K Units) by Application (2020-2025)
Table 61. Global Oncostatin M (OSM) Sales (K Units) by Application (2026-2031)
Table 62. Global Oncostatin M (OSM) Sales Market Share by Application (2020-2025)
Table 63. Global Oncostatin M (OSM) Sales Market Share by Application (2026-2031)
Table 64. Global Oncostatin M (OSM) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oncostatin M (OSM) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oncostatin M (OSM) Revenue Market Share by Application (2020-2025)
Table 67. Global Oncostatin M (OSM) Revenue Market Share by Application (2026-2031)
Table 68. Global Oncostatin M (OSM) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oncostatin M (OSM) Price (US$/Unit) by Application (2026-2031)
Table 70. Thermo Fisher Scientific Inc. Company Information
Table 71. Thermo Fisher Scientific Inc. Description and Business Overview
Table 72. Thermo Fisher Scientific Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Scientific Inc. Oncostatin M (OSM) Product
Table 74. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bio-Techne Oncostatin M (OSM) Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. Scientists Helping Scientists Company Information
Table 81. Scientists Helping Scientists Description and Business Overview
Table 82. Scientists Helping Scientists Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Scientists Helping Scientists Oncostatin M (OSM) Product
Table 84. Scientists Helping Scientists Recent Developments/Updates
Table 85. Abcam Limited Company Information
Table 86. Abcam Limited Description and Business Overview
Table 87. Abcam Limited Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abcam Limited Oncostatin M (OSM) Product
Table 89. Abcam Limited Recent Developments/Updates
Table 90. FUJIFILM Irvine Scientific Company Information
Table 91. FUJIFILM Irvine Scientific Description and Business Overview
Table 92. FUJIFILM Irvine Scientific Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. FUJIFILM Irvine Scientific Oncostatin M (OSM) Product
Table 94. FUJIFILM Irvine Scientific Recent Developments/Updates
Table 95. BD Biosciences Company Information
Table 96. BD Biosciences Description and Business Overview
Table 97. BD Biosciences Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Biosciences Oncostatin M (OSM) Product
Table 99. BD Biosciences Recent Developments/Updates
Table 100. Bio-Rad Laboratories, Inc. Company Information
Table 101. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 102. Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Product
Table 104. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 105. BPS Bioscience, Inc. Company Information
Table 106. BPS Bioscience, Inc. Description and Business Overview
Table 107. BPS Bioscience, Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BPS Bioscience, Inc. Oncostatin M (OSM) Product
Table 109. BPS Bioscience, Inc. Recent Developments/Updates
Table 110. Elabscience Company Information
Table 111. Elabscience Description and Business Overview
Table 112. Elabscience Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Elabscience Oncostatin M (OSM) Product
Table 114. Elabscience Recent Developments/Updates
Table 115. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
Table 116. Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Product
Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
Table 120. ENZO Company Information
Table 121. ENZO Description and Business Overview
Table 122. ENZO Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. ENZO Oncostatin M (OSM) Product
Table 124. ENZO Recent Developments/Updates
Table 125. Beijing Biocreative Technology Co., Ltd. Company Information
Table 126. Beijing Biocreative Technology Co., Ltd. Description and Business Overview
Table 127. Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Product
Table 129. Beijing Biocreative Technology Co., Ltd. Recent Developments/Updates
Table 130. Shanghai Yaji Biotechnology Co., Ltd. Company Information
Table 131. Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
Table 132. Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Product
Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recent Developments/Updates
Table 135. Cellverse Co., Ltd. Company Information
Table 136. Cellverse Co., Ltd. Description and Business Overview
Table 137. Cellverse Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Cellverse Co., Ltd. Oncostatin M (OSM) Product
Table 139. Cellverse Co., Ltd. Recent Developments/Updates
Table 140. Dalian Meilun Biotech Co., Ltd. Company Information
Table 141. Dalian Meilun Biotech Co., Ltd. Description and Business Overview
Table 142. Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Product
Table 144. Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
Table 145. Sino Biological,Inc. Company Information
Table 146. Sino Biological,Inc. Description and Business Overview
Table 147. Sino Biological,Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Sino Biological,Inc. Oncostatin M (OSM) Product
Table 149. Sino Biological,Inc. Recent Developments/Updates
Table 150. Prospec-Tany Technogene Ltd Company Information
Table 151. Prospec-Tany Technogene Ltd Description and Business Overview
Table 152. Prospec-Tany Technogene Ltd Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Prospec-Tany Technogene Ltd Oncostatin M (OSM) Product
Table 154. Prospec-Tany Technogene Ltd Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Oncostatin M (OSM) Distributors List
Table 158. Oncostatin M (OSM) Customers List
Table 159. Oncostatin M (OSM) Market Trends
Table 160. Oncostatin M (OSM) Market Drivers
Table 161. Oncostatin M (OSM) Market Challenges
Table 162. Oncostatin M (OSM) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oncostatin M (OSM)
Figure 2. Global Oncostatin M (OSM) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncostatin M (OSM) Market Share by Type: 2024 & 2031
Figure 4. Purity＜95% Product Picture
Figure 5. Purity ≥95% Product Picture
Figure 6. Global Oncostatin M (OSM) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Oncostatin M (OSM) Market Share by Application: 2024 & 2031
Figure 8. University
Figure 9. Research Center
Figure 10. Global Oncostatin M (OSM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Oncostatin M (OSM) Market Size (2020-2031) & (US$ Million)
Figure 12. Global Oncostatin M (OSM) Sales (2020-2031) & (K Units)
Figure 13. Global Oncostatin M (OSM) Average Price (US$/Unit) & (2020-2031)
Figure 14. Oncostatin M (OSM) Report Years Considered
Figure 15. Oncostatin M (OSM) Sales Share by Manufacturers in 2024
Figure 16. Global Oncostatin M (OSM) Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Oncostatin M (OSM) Players: Market Share by Revenue in Oncostatin M (OSM) in 2024
Figure 18. Oncostatin M (OSM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Oncostatin M (OSM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 21. North America Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 22. United States Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 25. Europe Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 26. Germany Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Oncostatin M (OSM) Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Oncostatin M (OSM) Revenue Market Share by Region (2020-2031)
Figure 33. China Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 41. Latin America Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Oncostatin M (OSM) by Type (2020-2031)
Figure 52. Global Revenue Market Share of Oncostatin M (OSM) by Type (2020-2031)
Figure 53. Global Oncostatin M (OSM) Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Oncostatin M (OSM) by Application (2020-2031)
Figure 55. Global Revenue Market Share of Oncostatin M (OSM) by Application (2020-2031)
Figure 56. Global Oncostatin M (OSM) Price (US$/Unit) by Application (2020-2031)
Figure 57. Oncostatin M (OSM) Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Oncostatin M (OSM) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Oncostatin M (OSM) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Oncostatin M (OSM) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oncostatin M (OSM) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Oncostatin M (OSM) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Oncostatin M (OSM) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Oncostatin M (OSM) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Oncostatin M (OSM) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Oncostatin M (OSM), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oncostatin M (OSM), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncostatin M (OSM), Product Type & Application
Table 12. Global Key Manufacturers of Oncostatin M (OSM), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncostatin M (OSM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncostatin M (OSM) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncostatin M (OSM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Oncostatin M (OSM) Sales by Region (2020-2025) & (K Units)
Table 18. Global Oncostatin M (OSM) Sales Market Share by Region (2020-2025)
Table 19. Global Oncostatin M (OSM) Sales by Region (2026-2031) & (K Units)
Table 20. Global Oncostatin M (OSM) Sales Market Share by Region (2026-2031)
Table 21. Global Oncostatin M (OSM) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Oncostatin M (OSM) Revenue Market Share by Region (2020-2025)
Table 23. Global Oncostatin M (OSM) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Oncostatin M (OSM) Revenue Market Share by Region (2026-2031)
Table 25. North America Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 27. North America Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 28. North America Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Oncostatin M (OSM) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Oncostatin M (OSM) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Oncostatin M (OSM) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Oncostatin M (OSM) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Oncostatin M (OSM) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Oncostatin M (OSM) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Oncostatin M (OSM) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Oncostatin M (OSM) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Oncostatin M (OSM) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Oncostatin M (OSM) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Oncostatin M (OSM) Sales (K Units) by Type (2020-2025)
Table 51. Global Oncostatin M (OSM) Sales (K Units) by Type (2026-2031)
Table 52. Global Oncostatin M (OSM) Sales Market Share by Type (2020-2025)
Table 53. Global Oncostatin M (OSM) Sales Market Share by Type (2026-2031)
Table 54. Global Oncostatin M (OSM) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Oncostatin M (OSM) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Oncostatin M (OSM) Revenue Market Share by Type (2020-2025)
Table 57. Global Oncostatin M (OSM) Revenue Market Share by Type (2026-2031)
Table 58. Global Oncostatin M (OSM) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Oncostatin M (OSM) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Oncostatin M (OSM) Sales (K Units) by Application (2020-2025)
Table 61. Global Oncostatin M (OSM) Sales (K Units) by Application (2026-2031)
Table 62. Global Oncostatin M (OSM) Sales Market Share by Application (2020-2025)
Table 63. Global Oncostatin M (OSM) Sales Market Share by Application (2026-2031)
Table 64. Global Oncostatin M (OSM) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Oncostatin M (OSM) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Oncostatin M (OSM) Revenue Market Share by Application (2020-2025)
Table 67. Global Oncostatin M (OSM) Revenue Market Share by Application (2026-2031)
Table 68. Global Oncostatin M (OSM) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Oncostatin M (OSM) Price (US$/Unit) by Application (2026-2031)
Table 70. Thermo Fisher Scientific Inc. Company Information
Table 71. Thermo Fisher Scientific Inc. Description and Business Overview
Table 72. Thermo Fisher Scientific Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Scientific Inc. Oncostatin M (OSM) Product
Table 74. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bio-Techne Oncostatin M (OSM) Product
Table 79. Bio-Techne Recent Developments/Updates
Table 80. Scientists Helping Scientists Company Information
Table 81. Scientists Helping Scientists Description and Business Overview
Table 82. Scientists Helping Scientists Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Scientists Helping Scientists Oncostatin M (OSM) Product
Table 84. Scientists Helping Scientists Recent Developments/Updates
Table 85. Abcam Limited Company Information
Table 86. Abcam Limited Description and Business Overview
Table 87. Abcam Limited Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Abcam Limited Oncostatin M (OSM) Product
Table 89. Abcam Limited Recent Developments/Updates
Table 90. FUJIFILM Irvine Scientific Company Information
Table 91. FUJIFILM Irvine Scientific Description and Business Overview
Table 92. FUJIFILM Irvine Scientific Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. FUJIFILM Irvine Scientific Oncostatin M (OSM) Product
Table 94. FUJIFILM Irvine Scientific Recent Developments/Updates
Table 95. BD Biosciences Company Information
Table 96. BD Biosciences Description and Business Overview
Table 97. BD Biosciences Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Biosciences Oncostatin M (OSM) Product
Table 99. BD Biosciences Recent Developments/Updates
Table 100. Bio-Rad Laboratories, Inc. Company Information
Table 101. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 102. Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories, Inc. Oncostatin M (OSM) Product
Table 104. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 105. BPS Bioscience, Inc. Company Information
Table 106. BPS Bioscience, Inc. Description and Business Overview
Table 107. BPS Bioscience, Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. BPS Bioscience, Inc. Oncostatin M (OSM) Product
Table 109. BPS Bioscience, Inc. Recent Developments/Updates
Table 110. Elabscience Company Information
Table 111. Elabscience Description and Business Overview
Table 112. Elabscience Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Elabscience Oncostatin M (OSM) Product
Table 114. Elabscience Recent Developments/Updates
Table 115. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
Table 116. Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Oncostatin M (OSM) Product
Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments/Updates
Table 120. ENZO Company Information
Table 121. ENZO Description and Business Overview
Table 122. ENZO Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. ENZO Oncostatin M (OSM) Product
Table 124. ENZO Recent Developments/Updates
Table 125. Beijing Biocreative Technology Co., Ltd. Company Information
Table 126. Beijing Biocreative Technology Co., Ltd. Description and Business Overview
Table 127. Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Beijing Biocreative Technology Co., Ltd. Oncostatin M (OSM) Product
Table 129. Beijing Biocreative Technology Co., Ltd. Recent Developments/Updates
Table 130. Shanghai Yaji Biotechnology Co., Ltd. Company Information
Table 131. Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
Table 132. Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shanghai Yaji Biotechnology Co., Ltd. Oncostatin M (OSM) Product
Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recent Developments/Updates
Table 135. Cellverse Co., Ltd. Company Information
Table 136. Cellverse Co., Ltd. Description and Business Overview
Table 137. Cellverse Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Cellverse Co., Ltd. Oncostatin M (OSM) Product
Table 139. Cellverse Co., Ltd. Recent Developments/Updates
Table 140. Dalian Meilun Biotech Co., Ltd. Company Information
Table 141. Dalian Meilun Biotech Co., Ltd. Description and Business Overview
Table 142. Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Dalian Meilun Biotech Co., Ltd. Oncostatin M (OSM) Product
Table 144. Dalian Meilun Biotech Co., Ltd. Recent Developments/Updates
Table 145. Sino Biological,Inc. Company Information
Table 146. Sino Biological,Inc. Description and Business Overview
Table 147. Sino Biological,Inc. Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Sino Biological,Inc. Oncostatin M (OSM) Product
Table 149. Sino Biological,Inc. Recent Developments/Updates
Table 150. Prospec-Tany Technogene Ltd Company Information
Table 151. Prospec-Tany Technogene Ltd Description and Business Overview
Table 152. Prospec-Tany Technogene Ltd Oncostatin M (OSM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Prospec-Tany Technogene Ltd Oncostatin M (OSM) Product
Table 154. Prospec-Tany Technogene Ltd Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Oncostatin M (OSM) Distributors List
Table 158. Oncostatin M (OSM) Customers List
Table 159. Oncostatin M (OSM) Market Trends
Table 160. Oncostatin M (OSM) Market Drivers
Table 161. Oncostatin M (OSM) Market Challenges
Table 162. Oncostatin M (OSM) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oncostatin M (OSM)
Figure 2. Global Oncostatin M (OSM) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncostatin M (OSM) Market Share by Type: 2024 & 2031
Figure 4. Purity＜95% Product Picture
Figure 5. Purity ≥95% Product Picture
Figure 6. Global Oncostatin M (OSM) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Oncostatin M (OSM) Market Share by Application: 2024 & 2031
Figure 8. University
Figure 9. Research Center
Figure 10. Global Oncostatin M (OSM) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Oncostatin M (OSM) Market Size (2020-2031) & (US$ Million)
Figure 12. Global Oncostatin M (OSM) Sales (2020-2031) & (K Units)
Figure 13. Global Oncostatin M (OSM) Average Price (US$/Unit) & (2020-2031)
Figure 14. Oncostatin M (OSM) Report Years Considered
Figure 15. Oncostatin M (OSM) Sales Share by Manufacturers in 2024
Figure 16. Global Oncostatin M (OSM) Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Oncostatin M (OSM) Players: Market Share by Revenue in Oncostatin M (OSM) in 2024
Figure 18. Oncostatin M (OSM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Oncostatin M (OSM) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 21. North America Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 22. United States Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 25. Europe Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 26. Germany Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Oncostatin M (OSM) Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Oncostatin M (OSM) Revenue Market Share by Region (2020-2031)
Figure 33. China Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 41. Latin America Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Oncostatin M (OSM) Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Oncostatin M (OSM) Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Oncostatin M (OSM) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Oncostatin M (OSM) by Type (2020-2031)
Figure 52. Global Revenue Market Share of Oncostatin M (OSM) by Type (2020-2031)
Figure 53. Global Oncostatin M (OSM) Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Oncostatin M (OSM) by Application (2020-2031)
Figure 55. Global Revenue Market Share of Oncostatin M (OSM) by Application (2020-2031)
Figure 56. Global Oncostatin M (OSM) Price (US$/Unit) by Application (2020-2031)
Figure 57. Oncostatin M (OSM) Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232